Opinion

Search/Filter
  • Markets and Medicines

    Published May 1, 2020
    Opinion -
    Would you try an unproven drug to treat COVID-19? Is it your right?
  • States Suspending Plastic Bag Bans in Response to COVID-19 Pandemic

    Published April 30, 2020
    Opinion -
    Numerous cities and states with plastic bag bans are suspending these policies in response to public health concerns raised about the safety of alternative reusable bags during the Coronavirus pandemic.
  • COVID-19: Where’s the Evidence on COVID-19 Treatment?

    Published April 29, 2020
    Opinion -
    The American Medical Association and many other professional organizations demand “peer-reviewed science” before they will recommend or even accept the re-purposing of a long-established anti-malaria drug to treat or prevent COVID-19.
  • Tale of Two Panics — Covid & Climate

    Published April 28, 2020
    Opinion -
    While they are occurring on vastly different time scales, the Covid-19 panic and the climate change panic are remarkably similar.
  • Dueling Meta-Studies

    Published April 27, 2020
    Opinion -
    Clinical trials do more than inform us whether a drug is effective. They inform us when a drug is effective, in what combinations, in what dosages, and what are the counter indications.
  • U.S. EPA, DOT, Promote Safety by Reducing Mandated Future Fuel Economy Increases

    Published April 23, 2020
    Opinion -
    The Trump administration finalized updates to the nation’s fuel economy standard, saying the new rule will better protect air quality, consumer choice, and public safety than the previous rule issued during Barack Obama’s presidency.
  • Is This a Recession?

    Published April 23, 2020
    Opinion -
    We have experienced unprecedented economic effects of the COVID-19 pandemic and social distancing policies. Twenty two million Americans lost jobs in four weeks.
  • Hydroxychloroquine Clinical Trials Effective in Silencing American Media

    Published April 22, 2020
    Opinion -
    The results of clinical trials are making their way to publication showing hydroxychloroquine to be effective in many, although possibly not all, situations. The American media is silent on these studies.
  • Mutating Virus Panic Into Climate Crisis Scares

    Published April 21, 2020
    Opinion -
    In the first several weeks of the COVID-19 pandemic, the media alternated between providing information on the scope and possible dreadful consequences of the contagion and vilifying President Trump over his supposed failures in managing the pandemic.
  • Sacrificing for a Collective Good

    Published April 20, 2020
    Opinion -
    The life values traded off in stay at home orders are fundamental to us as persons - how we face fear versus protecting our families. Freedom exists precisely so people not sharing the same values do not have to impose their choices on each other.
  • Did We Just Shut Down the Economy Because of a Flu?

    Published April 20, 2020
    Opinion -
    The results of the first scientific survey of serology in a well-defined population has been conducted and – guess what? – the mortality rate for Coronavirus is not much different from that of the ordinary flu.
  • Ten Years Out, Electronic Health Records Raise Ire

    Published April 17, 2020
    Opinion -
    Electronic Health Records (EHRs) were once touted as an easily transferrable, cost-effective way to record patient care, but more than a decade after their introduction, they are a subject of heated debate.
  • It’s Past Time to Defund the World Health Organization

    Published April 17, 2020
    Opinion -
    President Trump announced at the White House coronavirus press briefing on Tuesday that the United States will immediately halt all funding for the World Health Organization.
  • Should We Sue China Over COVID?

    Published April 17, 2020
    Opinion -
    Several lawsuits seek monetary damages from the Chinese government for the COVID-19 pandemic. Politicians seem to like the idea too.
  • Physicians Still Waiting for Flexibility in Prescribing to Suicidal Patients

    Published April 16, 2020
    Opinion -
    After publicly calling attention to the problem eight years, physicians say there has been little to no change in the way insurance companies cover prescription medications for suicidal patients considered in danger of a drug overdose.
  • COVID-19 Response Sets New Normal for Big Government

    Published April 15, 2020
    Opinion -
    During my last visit to the grocery store, the clerk directed me to the hermetically sealed conveyor belt and, grinning proudly, said, “Welcome to the new normal.”
  • WAGs and Convenience Samples

    Published April 15, 2020
    Opinion -
    We have yet to record meaningful samples of the general population with regard to the prevalence of coronavirus, the distribution of its outcomes, and the build-up of immunity.
  • Don’t Gobble Up Government Surveillance Just Because of COVID-19

    Published April 15, 2020
    Opinion -
    Due to coronavirus, governments across the globe are considering and/or are doing something they certainly could not do before: implement mass surveillance programs to track COVID-19 patients.
  • New Strategy on Patient Health Data Targets Consumers

    Published April 14, 2020
    Opinion -
    Before the Coronavirus pandemic took center stage, the Trump Administration began executing new rules for better production, use, and sharing of medical records.
  • The Time Has Come for Free-to-Choose Medicine

    Published April 14, 2020
    Opinion -
    If the COVID-19 crisis has taught us one thing—aside from the need to wash your hands often—it is that the FDA's approval process for much-needed medicine to those with debilitating and terminal diseases is in dire need of reform.
  • COVID-19: The Government Practice of Medicine

    Published April 14, 2020
    Opinion -
    I hope you are doing well--for access to medical help is increasingly threatened.
  • FDA Gives Biosimilars a Boost by Expanding Database

    Published April 13, 2020
    Opinion -
    The so-call "Purple Book" is a list of all licensed biologic products and is a reference guide for patients, providers, payers and manufactureres.
  • The Pandemic or the Recession: Which is More Costly?

    Published April 13, 2020
    Opinion -
    The United States has taken unprecedented actions to halt the spread of the novel coronavirus and the illness it causes, COVID-19. How bad will this be for the economy?
  • Litigation in the Public Interest?

    Published April 13, 2020
    Opinion -
    Fear of litigation delayed delivery of millions of N95 masks for healthcare workers. Should the law be slowing our emergency response?

Heartland Newsletters

The Heartland Institute offers free email subscriptions to all of its newsletters and monthly public policy newspapers.